Skip to main content

New Products

  • Teva launches generic version of AbbVie's Zemplar

    JERUSALEM — Generic drug maker Teva Pharmaceutical Industries has launched a version of a drug used to treat a parathyroid disorder related to kidney disease.

    Teva announced Tuesday the launch of paricalcitol, a generic version of AbbVie's Zemplar. As the first company to win Food and Drug Administration approval for the drug, Teva has 180 days in which to compete directly with the branded version.

  • New Disney Villains beauty collection available exclusively at Walgreens

    GLENDALE, Calif. — Beauty mavens can be wickedly beautiful this Halloween with the new Disney Villains collection now available at Walgreens stores nationwide.

  • SoloHealth survey finds widespread lack of awareness about health insurance marketplaces

    SANTA CLARA, Calif. — Most consumers have "no" or "a little bit" of knowledge about the health insurance marketplaces set to open on Tuesday, according to a new survey.

  • Yankee Candle introduces Thanksgiving fragrances

     SOUTH DEERFIELD, Mass. — Yankee Candle Co. has introduced its collection of scented, Thanksgiving-themed candles, the company said Monday.

    Yankee announced the launch of the Thanksgiving Dinner Collection, which includes such fragrances as Turkey with Stuffing, Cranberry Sauce and Sweet Potato Pie. For each candle sold, $1 will be donated to the USO. The donations will take place between Sept. 30 and Oct. 31, and will support the USO's Holiday Box program for military personnel stationed overseas.

  • New So Fresh So Clean line targets younger consumers

    NEW YORK — Global Beauty Care has announced the launch of its new So Fresh So Clean skin care line for tweens, teens and young adults.

    The collection includes:

  • Mylan launches generic anti-fungal drug

    PITTSBURGH — Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

    The drug maker announced the launch of voriconazole for oral suspension in the 40-mg-per-mL strength. The drug is the first generic version of Pfizer's Vfend, and as the first company to receive approval for a generic version, Mylan has 180 days in which to compete exclusively against Pfizer's product. The drug is used to treat invasive fungal infections.

  • ClarityMD line features new Clarifying Acne Treatment Pads

    WESTLAKE VILLAGE, Calif. — Envy Medical has expanded its ClarityMD line with the new Clarifying Acne Treatment Pads made with a gentle, alcohol-free formula that soothes skin with aloe.

  • FDA approves Genentech's Perjeta for early-stage breast cancer

    SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for treating early-stage breast cancer before surgery, the agency said Monday.

X
This ad will auto-close in 10 seconds